FENG; XIAODONG

Patent Applications and Registrations

Patent applications and USPTO patent grants for FENG; XIAODONG.The latest application filed is for "anti-angiogenic treatment using vlo4 with a blocking peptide".

Company Profile

3.8.14

FENG; XIAODONG - CARMICHAEL CA
Feng; Xiaodong - Qingdao CN
Feng; Xiaodong - Qingdao City CN
Feng; Xiaodong - Toronto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-angiogenic Treatment Using Vlo4 With A Blocking Peptide App 20220226431 - FENG; XIAODONG	2022-07-21
Anti-angiogenic treatment with a combination of antagonists Grant 11,318,184 - Feng May 3, 2	2022-05-03
High-low temperature radiator for internal combustion engine engineering machinery Grant 11,215,108 - Wang , et al. January 4, 2	2022-01-04
Combination Therapy For Inhibiting Sprout Angiogenesis App 20210169982 - FENG; XIAODONG	2021-06-10
Compositions for inhibiting sprout angiogenesis Grant 10,973,877 - Feng April 13, 2	2021-04-13
High-Low Temperature Radiator for Internal Combustion Engine Engineering Machinery App 20210079834 - Wang; Dengfeng ; et al.	2021-03-18
Compositions For Inhibiting Sprout Angiogenesis App 20210000918 - FENG; XIAODONG	2021-01-07
Anti-angiogenic Treatment With A Combination Of Antagonists App 20200397856 - FENG; XIAODONG	2020-12-24
Anti-angiogenic treatment of endothelial tissue with a combination of antagonists Grant 10,722,555 - Feng	2020-07-28
Anti-angiogenic Treatment Of Ovarian, Breast, And Prostate Cancer With A Combination Of Antagonists App 20150105320 - FENG; XIAODONG	2015-04-16
Administration of an antagonist of .alpha.5.beta.1 for anti-angiogenesis and cancer treatment Grant 8,946,159 - Feng February 3, 2	2015-02-03
Formulations having an antagonist of .alpha.5.beta.1 for anti-angiogenesis and cancer treatment Grant 8,815,805 - Feng August 26, 2	2014-08-26
Formulations Having An Antagonist Of Alpha 5 Beta 1 For Anti-angiogenesis And Cancer Treatment App 20130225495 - FENG; XIAODONG	2013-08-29
Administration of an antagonist of a5 1 for anti-angiogenesis and cancer treatment App 20130165380 - Feng; Xiaodong	2013-06-27
Combined Administration Of Integrin Receptor Antagonists For Anti-angiogenic Therapy App 20110319335 - FENG; XIAODONG	2011-12-29
Light-emitting devices with fullerene layer Grant 7,521,113 - Lu , et al. April 21, 2	2009-04-21
Top light-emitting devices with fullerene layer App 20060099448 - Lu; Zheng-Hong ; et al.	2006-05-11
Organoboron luminescent compounds and methods of making and using same App 20060036114 - Wang; Suning ; et al.	2006-02-16
Light-emitting devices with an embedded charge injection electrode App 20040245917 - Lu, Zheng-Hong ; et al.	2004-12-09
Light-emitting devices with fullerene layer App 20040214041 - Lu, Zheng-Hong ; et al.	2004-10-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.